Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2019 to Q2 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
HEPA on Nasdaq
Shares outstanding
11,764,939
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 4.9% -50% 576,482 -3.2% Anson Funds Management LP 30 Jun 2025

Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$58,764 0
2023 Q1 75,674 $58,764 +$3 $1.00 7
2022 Q4 280,899 $138,008 +$18,852 $0.44 7
2022 Q3 7,146,392 $3,611,286 -$218,778 $0.51 25
2022 Q2 7,406,219 $4,238,005 -$119,657 $0.57 26
2022 Q1 7,555,210 $9,738,515 -$280,794 $1.29 31
2021 Q4 7,899,837 $9,001,091 -$8,230 $1.14 39
2021 Q3 7,794,749 $11,923,898 -$5,020,175 $1.53 35
2021 Q2 10,707,068 $21,197,369 +$5,865,877 $1.98 41
2021 Q1 7,972,408 $14,665,458 +$3,900,185 $1.84 39
2020 Q4 5,465,996 $11,970,665 +$9,227,790 $2.19 28
2020 Q3 267,804 $832,000 +$409,972 $3.10 12
2020 Q2 140,957 $403,000 -$181,870 $2.87 5
2020 Q1 207,666 $367,000 -$227,082 $1.76 5
2019 Q4 178,669 $956,720 +$515,690 $5.36 11
2019 Q3 155,684 $377,000 +$377,000 $2.43 4